Homeopathic Topical Cream Recalled for Manufacturing Process Deviations
DISCOVERY PHARMA LLC voluntarily recalled 21,892 tubes of Conzerol zero molluscum contagiosum topical cream distributed in California, Florida, and Washington due to current good manufacturing practice deviations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary Class II recall with no reported illnesses or injuries. The recall was initiated due to current good manufacturing practice deviations, which constitute manufacturing process violations. Without reported harm or a specifically named safety hazard, this qualifies as a moderate-severity precautionary recall.
Plain-English summary
Conzerol zero molluscum contagiosum is a homeopathic topical cream (0.78 oz/22g tubes) manufactured by DISCOVERY PHARMA LLC. The product is intended as a topical treatment for molluscum contagiosum and was distributed in California, Florida, and Washington.
The FDA classified this recall as Class II and issued it in response to current good manufacturing practice (CGMP) deviations identified in the product's manufacturing process. The firm initiated the recall voluntarily in November 2022.
The recall affects 21,892 tubes with lot numbers 22123 (expiring January 2024) and 21732 (expiring July 2023). Consumers who have purchased this product should discontinue use and consult with their healthcare provider or pharmacist if they have concerns about their use of the product.
The recalled product
- Product
- Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland
- Manufacturer
- DISCOVERY PHARMA LLC
- Category
- Drug — Topical
- Hazard
- Affected units
- 21,892
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 22123 Exp. 01/2024
- 21732 Exp. 07/2023
Distribution
Related recalls
Same hazard · manufacturing defect
See all →- ModerateBoston Scientific Recalls Direxion Torqueable Microcatheters Due to Coating Defects
FDA (Devices) · 2026-10-28
- ModerateBoston Scientific Recalls Defective Direxion Torqueable Microcatheters
FDA (Devices) · 2026-10-28
- ModerateBoston Scientific Recalls Defective Direxion Torqueable Microcatheters
FDA (Devices) · 2026-10-28
- ModerateBoston Scientific Recalls Direxion Torqueable Microcatheters Due to Coating Defects
FDA (Devices) · 2026-10-28
- ModerateBoston Scientific Recalls Direxion Torqueable Microcatheters for Coating Defects
FDA (Devices) · 2026-10-28
Similar recalls
- ModerateElroselabs Recalls Conzerol Topical Cream Due to Manufacturing Deviations
FDA (Drugs) · 2018-04-18
- ModerateCura Hongos clotrimazole cream recalled over manufacturing practice deviations
FDA (Drugs) · 2026-06-24
- ModerateAntifungal Cream Recalled for Manufacturing Deviations
FDA (Drugs) · 2025-05-28
- ModerateAntifungal Drug Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-05-28
- ModerateMedorrhinum homeopathic drug recalled for manufacturing process deviations
FDA (Drugs) · 2022-06-22
- ModeratePharma-Natural Recalls Lid O Creme Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31